Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

735.20
+0.39000.05%
Post-market: 736.501.30+0.18%19:42 EDT
Volume:613.95K
Turnover:451.27M
Market Cap:75.69B
PE:18.18
High:742.50
Open:740.50
Low:729.20
Close:734.81
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.69
T/O Rate:0.62%
Dividend:3.64
Dividend Rate:0.50%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.39
PE(LYR):17.72

Loading ...

Movement Alert|Regeneron Pharmaceuticals Rises 3.19% in Regular Trading, Q2 Earnings Massively Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Shares up 1% After Upbeat Q2 Results

THOMSON REUTERS
·
Jul 30

Sanofi Expects Moderate Increases in R&D Spend

Reuters
·
Jul 30

Regeneron Publishes Corporate Presentation Highlighting Q2 Pipeline Progress and Product Sales Trends

Reuters
·
Jul 30

Regeneron Beats Quarterly Estimates on Eczema Drug Strength, Shares Rise

Reuters
·
Jul 30

U.S. Stocks on the MOVE-Fortinet, Regeneron, Cigna

Reuters
·
Jul 30

Sanofi CEO, on Regeneron Partnership, Says Co's Main Objective Has Been to Rebuild Trust

THOMSON REUTERS
·
Jul 30

Drug Maker Regeneron Gains After Upbeat Q2 Results

Reuters
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Stock Track | Regeneron Pharmaceuticals Soars 5.69% in Pre-market as Q2 Earnings Blow Past Estimates

Stock Track
·
Jul 30

Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 Vs. IBES Estimate USD 10.3

Reuters
·
Jul 30

Regeneron Q2 FY26 GAAP EPS Falls 5% to $12.23; Revenue Rises 17% to $4.3 Billion

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 4.25% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Q2 Adj. EPS $14.29 Beats $10.26 Estimate, Sales $4.291B Beat $3.816B Estimate

Benzinga Earnings
·
Jul 30

Regeneron Pharmaceuticals - Q2 Eylea Hd U.S. Net Sales up 52% to $596 Mln

THOMSON REUTERS
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 VS. Ibes Estimate USD 10.3

THOMSON REUTERS
·
Jul 30

Regeneron Outlook FY Capex USD 1,030-1,100 Million

THOMSON REUTERS
·
Jul 30

Regeneron Pharmaceuticals - Q2 Dupixent Global Net Sales Rise 38% to $6 Bln

THOMSON REUTERS
·
Jul 30